+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viral Vector Manufacturing Market - Global Forecast 2026-2032- Product Image
Viral Vector Manufacturing Market - Global Forecast 2026-2032- Product Image
New

Viral Vector Manufacturing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5613111
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The viral vector manufacturing market is rapidly reshaping the landscape for advanced therapies, presenting senior leadership with critical levers to drive quality, speed, and resilience across development and commercialization programs. Strategic investment in this sector is now essential for therapy developers and service providers adapting to evolving scientific, operational, and regulatory environments.

Market Snapshot

The Viral Vector Manufacturing Market grew from USD 11.00 billion in 2025 to USD 13.17 billion in 2026. It is expected to continue growing at a CAGR of 20.67%, reaching USD 41.00 billion by 2032.

Scope & Segmentation

This report examines the entire viral vector manufacturing ecosystem, providing an actionable framework for strategic decision-makers seeking clarity on market drivers and granular operational imperatives.

  • Vector Types: Covers adenoviral, baculoviral, herpes simplex, lentiviral, plasmid DNA, and retrovirus vectors, each with respective technical and regulatory demands impacting process and investment requirements.
  • Workflow Stages: Analyzes upstream and downstream processing including cell substrate choices, bioreactor configurations, transfection chemistries, purification platforms, and formulation options that shape throughput and quality.
  • Delivery Modalities: Explores differences between ex vivo and in vivo approaches, with emphasis on scalability, traceability, and formulation stability.
  • Technologies: Evaluates purification techniques such as chromatography and ultrafiltration, plus transfection methods including chemical-based and electroporation strategies critical for yield and viability.
  • Disease Indications & Applications: Profiles work in cardiovascular, genetic, infectious, and metabolic disorders, as well as gene therapy, oncology, and vaccinology applications, each requiring unique manufacturing and regulatory alignment.
  • End Users: Assesses needs across large and small biotech firms, pharmaceutical companies (manufacturing and R&D), and research institutions, each with distinct quality, technical, and commercialization priorities.
  • Regions: Details capacity, regulatory, and talent environment distinctions in the Americas; Europe, the Middle East, and Africa; and Asia-Pacific, highlighting strategic ramifications for supply chain and market entry.

Key Takeaways: Viral Vector Manufacturing Market

  • Viral vector manufacturing is now a mission-critical capability as advanced therapies demand higher quality, faster delivery, and enhanced regulatory compliance throughout process development and scale-up.
  • Integration of process automation and digital systems is advancing from pilot to GMP, providing greater consistency and speed while enabling modular and scalable manufacturing platforms that reduce project risk.
  • Supply chain resilience has become a strategic differentiator; organizations are diversifying suppliers, qualifying alternatives, and building safety stocks for critical components to safeguard clinical and commercial timelines.
  • Modular design and digital analytics in facility operations support faster reconfiguration, stronger traceability, and proactive risk mitigation in both clinical and commercial settings.
  • Strategic partnerships are evolving: many service providers and sponsors now collaborate with technology vendors and academic groups to drive rapid technology adoption and shared-risk scale-up models.
  • Regional strategies vary, with the Americas prioritizing innovation and quick regulatory engagement, Europe balancing regulatory diversity with cost-effective supply, and Asia-Pacific driving expansion through rapid technology adoption and robust local partnerships.

Tariff Impact on Procurement and Capacity Planning

Tariffs introduced in the United States in 2025 have significantly affected procurement choices, supplier diversification, and facility localization. Manufacturers now reevaluate inventory strategies, qualify new suppliers across regions, and adapt contracts for cost stability. Many are exploring modular and regional manufacturing hubs to minimize exposure to tariff-driven delays and price volatility, reinforcing the need for enterprise risk modeling and cross-functional scenario planning.

Methodology & Data Sources

This report’s findings are based on in-depth interviews with experts across process development, QC, supply chain, and regulatory functions, supported by secondary research from technical literature and regulatory guidance. Comparative process mapping and scenario testing strengthened the insights, while acknowledged limitations include evolving scientific progress and regulatory shifts that may impact future outcomes.

Why This Report Matters

  • Connects operational realities and market trends to deliver actionable strategies for accelerating advanced therapeutic programs while managing risk.
  • Equips decision-makers to benchmark supplier networks, technology platforms, and regional approaches, supporting informed resource allocation and capacity planning.

Conclusion

As viral vector manufacturing matures, platform investment, supply chain agility, and regulatory foresight will define competitive advantage. Senior leaders who act on these insights can improve program resilience and accelerate commercialization trajectories in a changing therapeutic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Viral Vector Manufacturing Market, by Vector Type
8.1. Adenoviral Vectors
8.2. Baculoviral Vectors
8.3. Herpes Simplex Vectors
8.4. Lentiviral Vectors
8.5. Plasmid DNA
8.6. Retrovirus
9. Viral Vector Manufacturing Market, by Workflow
9.1. Downstream Processing
9.1.1. Formulation
9.1.2. Purification
9.2. Upstream Processing
9.2.1. Bioreactors
9.2.2. Cell Culture Systems
9.2.3. Media Formulations
10. Viral Vector Manufacturing Market, by Delivery Method
10.1. Ex Vivo
10.1.1. Cell Re-infusion
10.1.2. Cell Transduction
10.2. In Vivo
10.2.1. Direct Injection
10.2.2. Intravenous Route
10.2.3. Oral Administration
11. Viral Vector Manufacturing Market, by Technology
11.1. Purification Techniques
11.1.1. Chromatography
11.1.2. Ultrafiltration
11.2. Transfection Methods
11.2.1. Chemical-Based
11.2.2. Electroporation
12. Viral Vector Manufacturing Market, by Disease Indication
12.1. Cardiovascular Diseases
12.2. Genetic Disorders
12.3. Infectious Diseases
12.4. Metabolic Disorders
13. Viral Vector Manufacturing Market, by Application
13.1. Gene Therapy
13.1.1. Inherited Disorders
13.1.2. Oncological Disorders
13.1.3. Single Gene Mutations
13.2. Oncology Research
13.2.1. Gene Inactivation
13.2.2. Oncolytic Virotherapy
13.2.3. Tumor Suppressor Genes
13.3. Vaccinology
13.3.1. Cancer Vaccines
13.3.2. Infectious Diseases
13.3.3. Zoonotic Diseases
14. Viral Vector Manufacturing Market, by End User
14.1. Biotechnology Companies
14.1.1. Large Enterprises
14.1.2. Start-Ups
14.2. Pharmaceutical Companies
14.2.1. Manufacturing
14.2.2. Research and Development
14.3. Research Institutions
14.3.1. Academic Laboratories
14.3.2. Government Labs
15. Viral Vector Manufacturing Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Viral Vector Manufacturing Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Viral Vector Manufacturing Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Viral Vector Manufacturing Market
19. China Viral Vector Manufacturing Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. ABL Inc.
20.6. Batavia Biosciences B.V. by CJ Cheiljedang
20.7. Biovian Oy
20.8. Charles River Laboratories International, Inc.
20.9. Creative Biogene
20.10. Danaher Corporation
20.11. FinVector Oy
20.12. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
20.13. GE HealthCare Technologies, Inc.
20.14. Genezen Laboratories, Inc.
20.15. Kaneka Eurogentec S.A.
20.16. Lonza Group Ltd.
20.17. MaxCyte, Inc.
20.18. Merck KGaA
20.19. Miltenyi Biotec GmbH
20.20. Novartis AG
20.21. Oxford Biomedica PLC
20.22. Sanofi SA
20.23. Sirion-Biotech GmbH
20.24. Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
20.25. Takara Bio Inc.
20.26. Thermo Fisher Scientific Inc.
20.27. uniQure N.V.
20.28. VGXI, Inc. by GeneOne Life Science
20.29. Waisman Biomanufacturing
20.30. Wuxi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ADENOVIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BACULOVIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BACULOVIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BACULOVIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY HERPES SIMPLEX VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LENTIVIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RETROVIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOREACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL CULTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL CULTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL CULTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MEDIA FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MEDIA FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MEDIA FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL RE-INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL RE-INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL RE-INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL TRANSDUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL TRANSDUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CELL TRANSDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DIRECT INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DIRECT INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DIRECT INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INTRAVENOUS ROUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INTRAVENOUS ROUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INTRAVENOUS ROUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ORAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ORAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHEMICAL-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHEMICAL-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CHEMICAL-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ELECTROPORATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ELECTROPORATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INHERITED DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INHERITED DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INHERITED DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SINGLE GENE MUTATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SINGLE GENE MUTATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SINGLE GENE MUTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE INACTIVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE INACTIVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE INACTIVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLYTIC VIROTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TUMOR SUPPRESSOR GENES, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TUMOR SUPPRESSOR GENES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TUMOR SUPPRESSOR GENES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY CANCER VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ZOONOTIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ZOONOTIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ZOONOTIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY START-UPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY START-UPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY START-UPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ACADEMIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ACADEMIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GOVERNMENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GOVERNMENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL VIRAL VECTOR MANUFACTURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 187. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 255. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 257. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 258. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 259. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 260. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 261. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 262. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 263. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 265. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 266. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 267. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 269. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 270. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 271. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 273. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 274. EUROPE VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VECTOR TYPE, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2032 (USD MILLION)
TABLE 280. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 281. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY EX VIVO, 2018-2032 (USD MILLION)
TABLE 282. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
TABLE 283. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PURIFICATION TECHNIQUES, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY TRANSFECTION METHODS, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY ONCOLOGY RESEARCH, 2018-2032 (USD MILLION)
TABLE 290. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2032 (USD MILLION)
TABLE 291. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST VIRAL VECTOR MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 295. AFRICA VIRAL VECTOR MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29

Companies Mentioned

The key companies profiled in this Viral Vector Manufacturing market report include:
  • ABL Inc.
  • Batavia Biosciences B.V. by CJ Cheiljedang
  • Biovian Oy
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Danaher Corporation
  • FinVector Oy
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • GE HealthCare Technologies, Inc.
  • Genezen Laboratories, Inc.
  • Kaneka Eurogentec S.A.
  • Lonza Group Ltd.
  • MaxCyte, Inc.
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Novartis AG
  • Oxford Biomedica PLC
  • Sanofi SA
  • Sirion-Biotech GmbH
  • Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.
  • VGXI, Inc. by GeneOne Life Science
  • Waisman Biomanufacturing
  • Wuxi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.17 Billion
Forecasted Market Value ( USD ) by 2032 $ 41 Billion
Compound Annual Growth Rate20.6%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Viral Vector & Plasmid DNA Manufacturing Market - Global Forecast 2026-2032 - Product Image

Viral Vector & Plasmid DNA Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Viral Vectors Market - Global Forecast 2026-2032 - Product Image

Viral Vectors Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Viral Vector Manufacturing - Global Strategic Business Report - Product Image

Viral Vector Manufacturing - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Viral Vector Production (Research-Use) Market - Global Strategic Business Report - Product Image

Viral Vector Production (Research-Use) Market - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Viral Vector Packaging Services Global Market Report 2025 - Product Image

Viral Vector Packaging Services Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Market

The Viral Vector Manufacturing market is a subset of the genomics industry that focuses on the production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, cystic fibrosis, and hemophilia. The Viral Vector Manufacturing market is highly competitive, with a number of companies offering a range of services. These services include vector design, vector production, and vector characterization. Companies also provide custom services to meet the specific needs of their customers. Some of the major players in the Viral Vector Manufacturing market include Lonza, Thermo Fisher Scientific, Merck KGaA, and Oxford BioMedica. These companies offer a range of services, from vector design to vector production and characterization. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.